Kits Eyecare Ltd
TSX:KITS
Kits Eyecare Ltd
TSX:KITS
Price:
6.3 CAD
Market Closed
Updated:
May 12, 2024
Balance Sheet
Balance Sheet Decomposition
Kits Eyecare Ltd
Kits Eyecare Ltd
| Current Assets | 34m |
| Cash & Short-Term Investments | 16m |
| Receivables | 1.8m |
| Other Current Assets | 16.1m |
| Non-Current Assets | 53.7m |
| PP&E | 8.7m |
| Intangibles | 39.3m |
| Other Non-Current Assets | 5.7m |
| Current Liabilities | 24.5m |
| Accounts Payable | 16m |
| Other Current Liabilities | 8.6m |
| Non-Current Liabilities | 11.7m |
| Long-Term Debt | 11.7m |
Balance Sheet
Kits Eyecare Ltd
Kits Eyecare Ltd
Currency: CAD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
3
|
3
|
3
|
2
|
21
|
19
|
16
|
|
| Cash Equivalents |
3
|
3
|
3
|
2
|
21
|
19
|
16
|
|
| Total Receivables |
2
|
1
|
1
|
1
|
1
|
1
|
2
|
|
| Accounts Receivables |
2
|
1
|
1
|
1
|
0
|
1
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
2
|
3
|
6
|
13
|
16
|
15
|
|
| Other Current Assets |
1
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
6
|
6
|
7
|
10
|
36
|
37
|
34
|
|
| PP&E Net |
0
|
0
|
1
|
2
|
11
|
10
|
9
|
|
| PP&E Gross |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
8
|
6
|
4
|
3
|
1
|
|
| Goodwill |
0
|
0
|
37
|
36
|
36
|
39
|
38
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
4
|
5
|
6
|
|
| Other Assets |
0
|
0
|
37
|
36
|
36
|
39
|
38
|
|
| Total Assets |
6
N/A
|
6
-2%
|
53
+791%
|
55
+2%
|
91
+66%
|
94
+3%
|
88
-7%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
2
|
5
|
10
|
8
|
14
|
13
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
2
|
2
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
23
|
22
|
4
|
4
|
4
|
|
| Other Current Liabilities |
4
|
2
|
2
|
3
|
3
|
4
|
5
|
|
| Total Current Liabilities |
5
|
4
|
31
|
35
|
17
|
24
|
25
|
|
| Long-Term Debt |
0
|
0
|
15
|
19
|
19
|
16
|
12
|
|
| Deferred Income Tax |
0
|
0
|
2
|
2
|
0
|
0
|
0
|
|
| Total Liabilities |
5
N/A
|
4
-14%
|
47
+970%
|
55
+17%
|
36
-35%
|
40
+11%
|
36
-10%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
7
|
7
|
77
|
77
|
77
|
|
| Retained Earnings |
1
|
2
|
0
|
7
|
21
|
26
|
28
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
1
|
2
|
3
|
3
|
|
| Other Equity |
0
|
0
|
1
|
2
|
3
|
0
|
1
|
|
| Total Equity |
1
N/A
|
2
+64%
|
6
+291%
|
1
N/A
|
55
N/A
|
54
-2%
|
51
-4%
|
|
| Total Liabilities & Equity |
6
N/A
|
6
-2%
|
53
+791%
|
55
+2%
|
91
+66%
|
94
+3%
|
88
-7%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
31
|
31
|
31
|
31
|
31
|
31
|
31
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
